Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Sposato (Grosseto, Italy), M. Latorre (Pisa, Italy), M. Scalese (Pisa, Italy), M. Bradicich (Pisa, Italy), S. Brighindi (Pisa, Italy), M. Daniele (Pisa, Italy), R. Del Cesta (Pisa, Italy), F. Dente (Pisa, Italy), A. Di Franco (Pisa, Italy), E. Bacci (Pisa, Italy), P. Paggiaro (Pisa, Italy). Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics. 950

Member's Comments

No comment yet.

Related content which might interest you: Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Blood eosinophils and exacerbation rate in COPD patients over three years Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004 Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Predictors of sputum eosinophilia in severe asthma Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Cytokines profile of blood and sputum in COPD exacerbation Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Cytokines profile of blood and sputum in COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Blood eosinophil in smokers and mild and moderate COPD patients Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study Source: International Congress 2016 – Systemic biomarkers Year: 2016 Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 Cytokine profile of blood and sputum at infectional COPD exacerbation Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Inflammatory cell counts in induced sputum from non-allergic asthmatics and COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002 Cytokine profile of blood and sputum in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006 Induced sputum and blood T lymphocyte activation during exacerbations of severe asthmatics: the ISEA study Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015